Sfoglia per AUTORE
VIGNETTI M
Collezione AOU Città della Salute di Torino

  

Items : 19

Safety Run-In and Part 1 of GIMEMA AML1718: Venetoclax Combined with FLAI as Induction Treatment in Non-Low-Risk AML. in Blood advances / Blood Adv. 2025 Mar 6:bloodadvances.2024014901. doi: 10.1182/bloodadvances.2024014901.

2025
AOU Città della Salute di Torino

Marconi G; Piciocchi A; Audisio E; Papayannidis C; Cerrano M; Minotti C; Paoloni F; Guolo F; Bocchia M; Rondoni M; Lico A; Carrabba MG; Della Porta MG; Frigeni M; Giaccone L; Beltrami G; Cattaneo C; Di Chio MC; Serio B; Crea E; Freilone R; Capria S; Curti A; Minetto P; la Sala E; Nanni J; Zannetti BA; Simonetti G; Bochicchio MT; et alii...

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...

Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group. in Annals of hematology / Ann Hematol. 2024 Oct;103(10):4329-4332. doi: 10.1007/s00277-024-05927-1. Epub 2024 Aug 8.

2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Busca A; Luppi M; Vignetti M; Candoni A; Santoni A; Pezone S; Perruccio K; Cattaneo C; Fracchiolla NS; Dargenio M; Zannier ME; Cerchione C; Audisio E; Melillo L; Delia M; Buquicchio C; Prezioso L; Guolo F; Fiorentini A; Bonanni M; Criscuolo M; Cavalieri E; Pasciolla C; Itri F; Del Principe MI; Marchesi F; Cordella S; Forghieri F; et alii...

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. in Cancer / Cancer. 2024 Jan;130(2):287-299. doi: 10.1002/cncr.35021. Epub 2023 Oct 6.

2024
AOU Città della Salute di Torino
AOU Novara

Cella D; Vignetti M; Cortes J; Rosti G; Dinner S; Altman JK; Abruzzese E; Fava C; Iurlo A; Giai V; Luciano L; Tiribelli M; Breccia M; Miggiano MC; Patriarca A; Capodanno I; Bonifacio M; Caocci G; Castagnetti F; Kota V; Yanez B; Cottone F; Efficace F;

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. in Blood / Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625.

2024
AOU Città della Salute di Torino
AOU Novara

Fazi P; Mengarelli A; Legrand O; Baron F; Candoni A; Posthuma EFM; Vrhovac R; Venditti A; Gaidano G; Crysandt M; Fuhrmann S; Foà R; Audisio E; Luppi M; Neubauer A; Griskevicius L; Chantepie S; Noppeney R; van der Velden WJFM; Coens C; Suciu S; Kicinski M; Efficace F; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA. in HemaSphere / Hemasphere. 2023 Aug 30;7(9):e944. doi: 10.1097/HS9.0000000000000944. eCollection 2023 Sep.

2023
AOU Città della Salute di Torino

Efficace F; Al Essa W; Platzbecker U; Niscola P; Palumbo GA; Caocci G; Cottone F; Breccia M; Luppi M; Stauder R; Ricco A; Petranovic D; Baron F; Voso MT; Fianchi L; Frairia C; Capodanno I; Sarlo C; Fedele M; Lemoli RM; Invernizzi R; Vallisa D; Di Renzo N; Fozza C; Doro M; Giesinger JM; Vignetti M;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study. in The lancet. Healthy longevity / Lancet Healthy Longev. 2022 Sep;3(9):e628-e635. doi: 10.1016/S2666-7568(22)00172-6.

2022
AOU Città della Salute di Torino

Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M;

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4370-4379. doi: 10.1182/bloodadvances.2021004649.

2021
AOU Città della Salute di Torino

Efficace F; Platzbecker U; Breccia M; Cottone F; Carluccio P; Salutari P; Di Bona E; Borlenghi E; Autore F; Levato L; Finizio O; Mancini V; D'Ardia S; Schlenk RF; Melillo L; Fumagalli M; Fiedler W; Beltrami G; Fracchiolla NS; Bernardi M; Fazi P; Annibali O; Mayer K; Voso MT; Vignetti M;

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Foà R; Cuneo A; Vignetti M; Gentile M; Montillo M; Marchetti M; Mauro FR; Crea E; Marasca R; Quaglia FM; Laurenti L; Molinari AL; Paolini R; Pietrasanta D; Sportoletti P; Varettoni M; Farina L; Murru R; Gaidano G; Cibien F; Vitagliano O; Coscia M; Zamprogna G; Visentin A; Reda G; Arena V; Cavazzini F; Piciocchi A; Rigolin GM; et alii...

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.

2020
AOU Città della Salute di Torino

Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). in Haematologica / Haematologica. 2020 Nov 1;105(11):2671-2674. doi: 10.3324/haematol.2019.235705.

2020
AOU Alessandria
AOU Città della Salute di Torino

Della Starza I; Del Giudice I; Cuneo A; Albano F; Neri A; Vignetti M; Piciocchi A; Nanni M; Musolino C; Del Poeta G; Battistini R; Gozzetti A; Pietrasanta D; Reda G; Tedeschi A; Liberati AM; Re F; Angelucci E; Zaja F; Coscia M; Ilariucci F; Soddu S; Molica S; Mauro FR; De Propris MS; Raponi S; Guarini AR; Foà R;

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.

2020
ASL Asti
AOU Città della Salute di Torino

Foà R; Ghia P; Cucci R; Vignetti M; Cavallari M; Cimino G; Ferrarini I; de la Serna J; Medina Perez A; Mauro FR; Di Raimondo F; Coscia M; Molica S; Farina L; Doubek M; Gaidano G; Ilariucci F; Marchetti M; Tedeschi A; Spacek M; Trentin L; Billio A; Roeker L; Orlandi EM; Ujjani CS; Shah NN; Sehgal AR; Schuster SJ; Pu JJ; et alii...

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial. in Leukemia / Leukemia. 2020 Mar;34(3):914-918. doi: 10.1038/s41375-019-0589-3. Epub 2019 Oct 14.

2020
AOU Città della Salute di Torino

Fabbiano F; Di Renzo N; Cortelezzi A; Maria D'Arco A; Fozza C; Frairia C; Link H; Schmitz N; Rollig C; Hanel M; Brandts CH; Lubbert M; Wattad M; Annibali O; Salih HR; Hertenstein B; Fiedler W; Brossart P; La Nasa G; Melillo L; Rambaldi A; Cairoli R; Borlenghi E; Breccia M; Sborgia M; Di Bona E; Efficace F; Albano F; Divona M; et alii...

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.

2020
AOU Città della Salute di Torino
AOU Novara

Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;

Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. in Leukemia / Leukemia. 2019 Jul;33(7):1598-1607. doi: 10.1038/s41375-018-0325-4. Epub 2018 Dec 20.

2019
AOU Città della Salute di Torino

Crugnola M; Nadali G; Cantore N; Nobile F; D'Ardia S; Sborgia M; Romani C; Luppi M; Rodeghiero F; Fabbiano F; Carluccio P; Borlenghi E; Intermesoli T; Cottone F; Avvisati G; Breccia M; Efficace F; Vignetti M; Amadori S; Lo Coco F; Efficace F; Breccia M; Avvisati G; Cottone F; Intermesoli T; Borlenghi E; Carluccio P; Rodeghiero F; Fabbiano F; et alii...

Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. in Leukemia & lymphoma / Leuk Lymphoma. 2019 Dec;60(14):3482-3492. doi: 10.1080/10428194.2019.1639170. Epub 2019 Jul 12.

2019
AOU Città della Salute di Torino

Bassan R; Fumagalli M; Chiaretti S; Audisio E; Cascavilla N; Paolini S; Delia M; Cerqui E; Micò C; Fabbiano F; Canichella M; Scattolin AM; Perfetti P; Paoloni F; Iodice M; Vitale A; Della Starza I; Fazi P; Vignetti M; Foà R;

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.

2017
AOU Città della Salute di Torino

Lo-Coco F; Schlenk RF; Ehninger G; Mandelli F; Amadori S; Döhner H; Ganser A; Döhner K; Fabbiano F; Cortelezzi A; Di Renzo N; D'Arco AM; Fozza C; Pogliani EM; Frairia C; Link H; Schmitz N; Röllig C; Hänel M; Brandts CH; Lübbert M; Wattad M; Salih HR; Hertenstein B; Brossart P; Fiedler W; La Nasa G; Melillo L; Rambaldi A; et alii...